ViroCell Biologics, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) specializing in GMP viral vector manufacturing for clinical trials, is expanding its U.S. business development team with the appointments of Meredith Brown as Senior Director and Elaine Rihn as Director of Business Development.   Both join from Lonza Inc., where their roles focused on generating and expanding commercial contracts with clients in CGT manufacturing. Brown and Rihn will fo...